MoonLake Immunotherapeutics (MLTX)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
19. 68
+0.67
+3.5245%
$
1.61B Market Cap
- P/E Ratio
- Div Yield
726,100 Volume
-1.16 Eps
$ 19.01
Previous Close 
Want to track MLTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
MoonLake Immunotherapeutics (MLTX) Statistics
Valuation metrics
Market Cap 1.61B
Enterprise value 1.43B
Trailing P/E (ttm) -5.07
Forward P/E -
PEG ratio 0.11
Price/Sales (ttm) -
Price/Book (mrq) 5.52
Enterprise Value/Revenue -
Enterprise Value/EBITDA -5.81
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 719.37K
Average volume (90 days) 1M
Price summary
52-Week low 5.95
52-Week high 62.75
Beta -
50-Day moving average 18.89
200-Day moving average 17.02
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.64%
Return on equity -0.86%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.61
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.02
Total debt (mrq) -
Total Debt/Equity (mrq) 0.4
Current ratio (mrq) 8.6%
Book value per share (mrq) 3.56
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
